Determination of HER2 in Gastric Cancer (GC) is still challenging: high deviation rates between local and central pathologies and its impact on survival

I Haffner; B. Luber; D. Maier; B. Geier; E. Raimundez; J. Hasenhauer; A. Kretzschmar; Fischer L. von Weikersthal; M. Ahlborn; Riera J. Knorrenschild; B. Rau; G. Siegler; S. Fuxius; T. Decker; K. Schierle; C. Wittekind; F. Lordick

Determination of HER2 in Gastric Cancer (GC) is still challenging: high deviation rates between local and central pathologies and its impact on survival

I Haffner
, B. Luber
, D. Maier
, B. Geier
, E. Raimundez
, J. Hasenhauer
, A. Kretzschmar
, Fischer L. von Weikersthal
, M. Ahlborn
, Riera J. Knorrenschild
, B. Rau
, G. Siegler
, S. Fuxius
, T. Decker
, K. Schierle
, C. Wittekind
, F. Lordick

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

Original language	Undefined/Unknown
Journal	Oncology Research and Treatment
Publication status	Published - 2018

Cite this

Haffner, I., Luber, B., Maier, D., Geier, B., Raimundez, E., Hasenhauer, J., Kretzschmar, A., von Weikersthal, F. L., Ahlborn, M., Knorrenschild, R. J., Rau, B., Siegler, G., Fuxius, S., Decker, T., Schierle, K., Wittekind, C., & Lordick, F. (2018). Determination of HER2 in Gastric Cancer (GC) is still challenging: high deviation rates between local and central pathologies and its impact on survival. Oncology Research and Treatment.

@article{a07c8270582f4ab794eeac096386e99e,

title = "Determination of HER2 in Gastric Cancer (GC) is still challenging: high deviation rates between local and central pathologies and its impact on survival",

author = "I Haffner and B. Luber and D. Maier and B. Geier and E. Raimundez and J. Hasenhauer and A. Kretzschmar and \{von Weikersthal\}, \{Fischer L.\} and M. Ahlborn and Knorrenschild, \{Riera J.\} and B. Rau and G. Siegler and S. Fuxius and T. Decker and K. Schierle and C. Wittekind and F. Lordick",

year = "2018",

language = "Undefined/Unknown",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "Karger ",

}

Haffner, I, Luber, B, Maier, D, Geier, B, Raimundez, E, Hasenhauer, J, Kretzschmar, A, von Weikersthal, FL, Ahlborn, M, Knorrenschild, RJ, Rau, B, Siegler, G, Fuxius, S, Decker, T, Schierle, K, Wittekind, C & Lordick, F 2018, 'Determination of HER2 in Gastric Cancer (GC) is still challenging: high deviation rates between local and central pathologies and its impact on survival', Oncology Research and Treatment.

TY - JOUR

T1 - Determination of HER2 in Gastric Cancer (GC) is still challenging: high deviation rates between local and central pathologies and its impact on survival

AU - Haffner, I

AU - Luber, B.

AU - Maier, D.

AU - Geier, B.

AU - Raimundez, E.

AU - Hasenhauer, J.

AU - Kretzschmar, A.

AU - von Weikersthal, Fischer L.

AU - Ahlborn, M.

AU - Knorrenschild, Riera J.

AU - Rau, B.

AU - Siegler, G.

AU - Fuxius, S.

AU - Decker, T.

AU - Schierle, K.

AU - Wittekind, C.

AU - Lordick, F.

PY - 2018

Y1 - 2018

UR - https://publons.com/wos-op/publon/27618473/

M3 - Original Article

SN - 2296-5270

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

ER -

Determination of HER2 in Gastric Cancer (GC) is still challenging: high deviation rates between local and central pathologies and its impact on survival

Other files and links

Cite this